logo

For the Inventor, By the Inventor

Blaubeuren, Germany

Merckle Gmbh


USPTO Granted Patents = 26

% Expired Patents = 42.3


Forward Citations = 240

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Stefan Laufer (12 out of 22 patents)

silverMedal Hans-Guenter Striegel (6 out of 6 patents)

bronzeMedal Gerd Dannhardt (5 out of 13 patents)

4.  Karola Tollmann (5 out of 6 patents)

5.  Philipp Merckle (4 out of 4 patents)

6.  Gunter Metz (4 out of 8 patents)

7.  Thomas Kammermeier (3 out of 3 patents)

8.  Matthias Lehr (3 out of 3 patents)

9.  Kurt Rauchle (3 out of 3 patents)

10.  Hans Gunther Striegel (3 out of 3 patents)

11.  Wolfgang Albrecht (2 out of 44 patents)

12.  Susanne Tries (2 out of 2 patents)

13.  Eberhard P Hofer (2 out of 2 patents)

14.  Christian Rembe (2 out of 2 patents)

15.  Manfred Erdmann (1 out of 3 patents)


Core Competencies:
Pyrrole Derivatives
2-Thio-Substituted Imidazoles
Antibiotic Conjugates
Anti-Inflammatory Agents
Tissue Factor
Macromolecule Synthesis
CD 137
Flufenamic Acid
Liquid Diclofenac
Injectable Solutions

26 patents:

1. 8034837 - Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2011-10-11),
2. 7608633 - [object Object] (2009-10-27),
3. 7442713 - 2-thio-substituted imidazole derivatives and their use in pharmaceutics (2008-10-28),
4. 7425573 - Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration (2008-09-16),
5. 7271154 - Antibiotic conjugates (2007-09-18),
6. 7253191 - 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry (2007-08-07),
7. 7078535 - Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid (2006-07-18),
8. 6936632 - Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof (2005-08-30),
9. 6930094 - Tissue factor for influencing blood vessel formation (2005-08-16),
10. 6878738 - Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use (2005-04-12),
11. 6867211 - 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy (2005-03-15),
12. 6627200 - Utilization of CD 137 in order to promote the proliferation of peripheral monocytes (2003-09-30),
13. 6544775 - Automated macromolecule synthesizing process and device (2003-04-08),
14. 6505914 - Microactuator based on diamond (2003-01-14),
15. 6432988 - 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine (2002-08-13),
Merckle GmbH, based in Blaubeuren, Germany, is a prominent player in the pharmaceutical and healthcare sectors. The company specializes in the development and manufacturing of high-quality generic medications, focusing on providing accessible healthcare solutions. With a commitment to innovation, Merckle engages in extensive research and development activities, particularly in the fields of oncology, cardiology, and central nervous system disorders. Its strategic initiatives aim to enhance therapeutic options and improve patient outcomes globally.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Merckle Gmbh
26 Patents

#1 in Blaubeuren

#1,783 in Germany

#24,758 in the World

Blaubeuren, DE
Blaubeuren, Germany

Merckle Gmbh

Forward Citations = 240

42 inventors:

goldMedal Stefan Laufer (12 out of 22 patents)

silverMedal Hans-Guenter Striegel (6 out of 6 patents)

bronzeMedal Gerd Dannhardt (5 out of 13 patents)

4.  Karola Tollmann (5 out of 6 patents)

5.  Philipp Merckle (4 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…